This protocol is judged by an institutional assessment board, an independent team that opinions any medical trials involving humans. If a review includes a Routine I drug, after the board approves the protocol as ethical, the researchers have to apply for an investigational new drug (IND) amount from the FDA.“It’s vital that you remember that t… Read More